J. Wu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
J. Wu has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
L. Liu
The Center of Cell Biological Treatment, General Hospital of Guangzhou Military Command of PLA, Guangzhou, Guangdong province, China
2 shared publicationsW. Li
Laboratory Medicine, General Hospital of Guangzhou Military Command of PLA, Guangzhou, Guangdong province, China
2 shared publicationsY. Peng
Geriatrics Center, General Hospital of Guangzhou Military Command of PLA, Guangzhou, Guangdong province, China
2 shared publicationsZ. Liu
Geriatrics Center, General Hospital of Guangzhou Military Command of PLA, Guangzhou, Guangdong province, China
2 shared publicationsB. Dai
Medical Laboratory
1 shared publicationD. Feng
Medical Laboratory
1 shared publication
Latest Publications
- Open Access
- 24 March 2012
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 75 (6) , 641-646
Ageing‐Associated Changes in Cellular Immunity Based on the SENIEUR Protocol
To investigate ageing‐associated changes in cellular immunity, we recruited three groups of healthy subjects based on SENIEUR protocol criteria. In addition, 10 subjects were randomly selected from each group to isolate their T cells from peripheral blood mononuclear cells; T cell proliferation after phytohemagglutinin (PHA) stimulation was determined by methyl thiazolyl tetrazolium assays. There were no marked differences in the absolute numbers of peripheral blood T cells, NK cells or B cells among the three groups (P > 0.05). Also, no significant differences were noted in the numbers of CD4+ cells, CD8+ cells, or the CD4+/CD8+ ratios (P > 0.05). After PHA stimulation, T cell proliferation was markedly increased, with the highest level in group C and the lowest level in group A (P < 0.05). Cytokine‐induced killer tumouricidal activities were also dramatically increased, with the highest activity in group C and the lowest activity in group A (P < 0.05). Our findings suggest that the number of immune cells remains unchanged with advanced age. However, there is a trend for decreased cellular immunity with an increase in age.
- 24 March 2012
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 75 (6) , 641-646
Open AccessAgeing‐Associated Changes in Cellular Immunity Based on the SENIEUR Protocol
To investigate ageing‐associated changes in cellular immunity, we recruited three groups of healthy subjects based on SENIEUR protocol criteria. In addition, 10 subjects were randomly selected from each group to isolate their T cells from peripheral blood mononuclear cells; T cell proliferation after phytohemagglutinin (PHA) stimulation was determined by methyl thiazolyl tetrazolium assays. There were no marked differences in the absolute numbers of peripheral blood T cells, NK cells or B cells among the three groups (P > 0.05). Also, no significant differences were noted in the numbers of CD4+ cells, CD8+ cells, or the CD4+/CD8+ ratios (P > 0.05). After PHA stimulation, T cell proliferation was markedly increased, with the highest level in group C and the lowest level in group A (P < 0.05). Cytokine‐induced killer tumouricidal activities were also dramatically increased, with the highest activity in group C and the lowest activity in group A (P < 0.05). Our findings suggest that the number of immune cells remains unchanged with advanced age. However, there is a trend for decreased cellular immunity with an increase in age.
- 14 November 2011
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 74 (6) , 603-608
Age‐Dependent Alterations of HLA‐DR Expression and Effect of Lipopolysaccharide on Cytokine Secretion of Peripheral Blood Mononuclear Cells in the Elderly Population
HLA-DR, a major histocompatibility complex, MHC class II, is involved in several autoimmune conditions, disease susceptibility and disease resistance. Here, we investigate the impact of different age individuals on HLA-DR expression on peripheral blood mononuclear cells (PBMCs) induced by lipopolysaccharide (LPS). The results indicate that HLA-DR expression on PBMCs in the population aged above 70 years significantly increased as compared with that in the lower-age groups by flow cytometry analysis (B-D; r = 0.690, P = 0.000265). In addition, followed by LPS stimulation, the levels of cytokine TNF-α, IL-6 and IL-10 secretion by allogeneic T lymphocytes from different age groups (A-D) were significantly increased (P < 0.05). Notably, levels of TNF-α and IL-6 were significantly reduced in groups B, C and D as compared with group A (P < 0.05), whereas levels of IL-10 increased (P = 0.012). However, no significant difference in PBMC-secreted TNF-α, IL-6 and IL-10 levels was observed among groups A, B, C and D (P > 0.05) before LPS stimulation. We firstly present data showing an age-dependent increase in HLA-DR expression in the population aged above 70 years and the individual with aged above 70 years has reduced the secretion of inflammatory mediators (TNF-α and IL-6) by PBMCs and increased the secretion of anti-inflammatory cytokine (IL-10) after LPS stimulation in vitro. The better understanding of HLR-DR expression on human PBMCs in aged individuals and its relation to the host cellular immunity would provide important insights into the immunity of aged individuals and particularly, in elderly patients with sepsis.
- 14 November 2011
- Published by Wiley in Scandinavian Journal of Immunology
- Vol. 74 (6) , 603-608
Age‐Dependent Alterations of HLA‐DR Expression and Effect of Lipopolysaccharide on Cytokine Secretion of Peripheral Blood Mononuclear Cells in the Elderly Population
HLA-DR, a major histocompatibility complex, MHC class II, is involved in several autoimmune conditions, disease susceptibility and disease resistance. Here, we investigate the impact of different age individuals on HLA-DR expression on peripheral blood mononuclear cells (PBMCs) induced by lipopolysaccharide (LPS). The results indicate that HLA-DR expression on PBMCs in the population aged above 70 years significantly increased as compared with that in the lower-age groups by flow cytometry analysis (B-D; r = 0.690, P = 0.000265). In addition, followed by LPS stimulation, the levels of cytokine TNF-α, IL-6 and IL-10 secretion by allogeneic T lymphocytes from different age groups (A-D) were significantly increased (P < 0.05). Notably, levels of TNF-α and IL-6 were significantly reduced in groups B, C and D as compared with group A (P < 0.05), whereas levels of IL-10 increased (P = 0.012). However, no significant difference in PBMC-secreted TNF-α, IL-6 and IL-10 levels was observed among groups A, B, C and D (P > 0.05) before LPS stimulation. We firstly present data showing an age-dependent increase in HLA-DR expression in the population aged above 70 years and the individual with aged above 70 years has reduced the secretion of inflammatory mediators (TNF-α and IL-6) by PBMCs and increased the secretion of anti-inflammatory cytokine (IL-10) after LPS stimulation in vitro. The better understanding of HLR-DR expression on human PBMCs in aged individuals and its relation to the host cellular immunity would provide important insights into the immunity of aged individuals and particularly, in elderly patients with sepsis.